logo
Share SHARE
FONT-SIZE Plus   Neg

Halozyme Q1 Loss Widens - Quick Facts

Halozyme Therapeutics, Inc. (HALO) Monday reported a first-quarter loss of $15.1 million or $0.14 per share, which widened from $9.6 million or $0.10 per share in the year-ago period.

On average, eight analysts polled by Thomson Reuters expected the company to report a loss of $0.11 per share for the first quarter. Analysts' estimates typically exclude special items.

First-quarter revenues declined to $7.4 million from $7.5 million last year. Analysts expected revenues of $7.31 million for the quarter.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Shares of Dave & Buster's Entertainment, Inc. (PLAY) offer a compelling value proposition at the current price. We believe the stock has at least 15% upside from present levels. Despite its presence in the troubled casual-dining sector, Dave & Buster's Entertainment bucks the trend by differentiating its offerings and guest experience. French energy giant Total SA announced Monday that it has agreed to acquire E&P company Maersk Oil & Gas A/S, a unit of A.P. Moller-Maersk A/S, in a $7.45 billion share and debt transaction. Under the agreed terms, the Denmark-based shipping and oil company will receive a consideration of $4.95 billion in Total shares. A.P. Moller-Maersk shares were gaining around 4 percent. Cable-cutters have now one more reason to do so as live television streaming will be available on YouTube TV in 14 more markets in the U.S.
comments powered by Disqus
Follow RTT